Mkts

Bicycle Therapeutics plc

NASDAQ: BCYC
$3.05-0.06 (-1.93%)
As of Nov 19, 4:00 PM ET

Key statistics

Day range
3.043.18
52-week range
3.077.83
Today
Open3.13
Previous close3.05
Volume411.5K
Valuation
Market cap217.68M
P/E ratio—
EPS (TTM)-2.03
Income & risk
Dividend / yield—
Beta1.59
Avg volume397.0K
Discussion

BCYC News

Stories mentioning BCYC from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue887.0047,95511,7342,9209,9773,7082,6769,361
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development48,90151,77058,42671,02959,05849,77848,26540,059
Sales General & Admin
Total Operating Expenses66,36972,66377,28589,52280,18171,37166,52256,008
Operating Income (Loss)(65,482)(24,708)(65,551)(86,602)(70,204)(67,663)(63,846)(46,647)
Interest Income
Interest Expense
Other Expense
Pretax Income(60,653)(18,889)(58,895)(79,183)(61,841)(52,936)(54,250)(39,697)
Tax Provision172.001,265205.00(231.00)(1,087)(1,082)(3,448)115.00
Net Income (Loss)(60,825)(20,154)(59,100)(78,952)(60,754)(51,854)(50,802)(39,812)
Earnings Per Share (Basic)(0.87)(0.29)(0.85)(1.14)(0.88)(0.89)(0.74)(0.77)
Earnings Per Share (Diluted)(0.87)(0.29)(0.85)(1.14)(0.88)(0.89)(0.74)(0.77)
Weighted Average Shares Outstanding (Basic)69,68369,28069,30469,25269,19758,20868,98951,992
Weighted Average Shares Outstanding (Diluted)69,68369,28069,30469,25269,19758,20868,98951,992

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BCYC

Bicycle Therapeutics plc (NASDAQ: BCYC) is a stock listed on the Nasdaq Stock Market under the ticker symbol BCYC. It last traded at $3.05 (Nov 19, 2026, 4:00 PM ET), down 1.9% on the day. That gives Bicycle Therapeutics a market capitalisation of $217.7M.

Over the past 52 weeks BCYC has traded between $3.07 and $7.83.

Revenue for the quarter ended Mar 31, 2026 was $887.0K; a net loss of $60.8M. Revenue was down 91.1% from $10.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$887.0K-$60.8M-6857.4%
Dec 31, 2025$48.0M-$20.2M-42.0%
Sep 30, 2025$11.7M-$59.1M-503.7%
Jun 30, 2025$2.9M-$79.0M-2703.8%

From Bicycle Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…